GLP-1 prescriptions for weight loss soar 587% in five years The percentage of adult patients with a diagnosis of overweight or obesity increased from 10.4% in 2019 to 15.7% in 2024.

Analysts say the number of private prescriptions for fat busting jabs like Ozempic in the UK are predicted to soar to over 1million next year, if current skyrocketing demand continues.

Teen Ozempic prescriptions are skyrocketing, but doctors warn of long-term risks and unknown side effects. Here's what parents need to know.

GLP-1 prescriptions for weight loss are shooting up, despite obstacles The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

Alabama ranks fifth in the nation for GLP-1 prescriptions, a class of drugs that includes Ozempic. The state saw nearly 20,000 GLP-1 prescriptions per 100,000 residents in 2024, a slight increase ...

Healthcare professionals write millions of prescriptions every year to help Americans manage symptoms and treat a range of conditions. But affordability, access issues, and drug shortages prevent ...

Wegovy prescriptions for teens rose 50 percent since 2023, a new report found — here's what parents should know about the GLP-1 weight-loss drug.

Ozempic is what's known as a GLP-1, a drug class that's prescribed to manage Type 2 diabetes and is effective for weight loss.

Online companies marketing directly to consumers are selling naltrexone, Viagra, and Ozempic. Some studies show Ozempic itself may decrease alcohol abuse.